Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations.
about
Gene mutation discovery research of non-smoking lung cancer patients due to indoor radon exposureNext-generation sequencing: advances and applications in cancer diagnosisTowards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions.Mutation testing for directing upfront targeted therapy and post-progression combination therapy strategies in lung adenocarcinoma.A simple method based on Sanger sequencing and MS Word wildcard searching to identify Cas9-induced frameshift mutations.Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapiesCell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer.NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?Hitherto unseen survival in an ALK-positive-patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine.Workflow optimization of whole genome amplification and targeted panel sequencing for CTC mutation detection.Cancer gene profiling in non-small cell lung cancers reveals activating mutations in JAK2 and JAK3 with therapeutic implications.Comparison of cross-platform technologies for EGFR T790M testing in patients with non-small cell lung cancer.Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.Validation of the digital PCR system in tyrosine kinase inhibitor-resistant EGFR mutant non-small-cell lung cancer.
P2860
Q26764865-59CBDC79-97DB-45BD-A82A-55A4BDA4B928Q28073891-41905ED2-7E59-4028-90E6-AA31D57FD237Q36264188-FDA6439F-4C30-4551-B476-7FFEADBB18F2Q37051546-767A3CE5-9BBD-40DD-BA6A-63B21DA06C88Q38616274-F9500B30-B356-4122-9ED7-E1F16040D79DQ38736110-459484DB-07F9-4245-843B-A42E2C7A54AEQ38824891-BBCCF250-F4E1-4BD9-95CF-C4F4D54422FAQ42695934-46C3EFC9-818E-4013-BD55-7DDB2DDF4239Q47124811-F46CC32E-9F97-48FA-821F-22BF36AB462FQ47146388-8FC32F04-CB5A-4CE8-9CD5-B2D7468F2F72Q47151526-0148337E-C326-4487-89C8-CE7577A2E428Q47162466-444A7D6D-1CBC-4A90-A8A3-4ADB1A8A0B65Q48292408-6043678A-1545-424D-AFFE-1720267967E2Q48505836-0A9EA75C-6AE0-4BB9-868F-602E14CDD880
P2860
Next-generation sequencing of tyrosine kinase inhibitor-resistant non-small-cell lung cancers in patients harboring epidermal growth factor-activating mutations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Next-generation sequencing of ...... h factor-activating mutations.
@ast
Next-generation sequencing of ...... h factor-activating mutations.
@en
type
label
Next-generation sequencing of ...... h factor-activating mutations.
@ast
Next-generation sequencing of ...... h factor-activating mutations.
@en
prefLabel
Next-generation sequencing of ...... h factor-activating mutations.
@ast
Next-generation sequencing of ...... h factor-activating mutations.
@en
P2093
P2860
P1433
P1476
Next-generation sequencing of ...... h factor-activating mutations.
@en
P2093
Akito Hata
Chiyuki Okuda
Jumpei Takeshita
Katsuhiro Masago
Kyoko Otsuka
Miho Muraki
Nobuyuki Katakami
Reiko Kaji
Ryoji Kato
Yukio Hirata
P2860
P2888
P356
10.1186/S12885-015-1925-2
P407
P50
P577
2015-11-16T00:00:00Z
P5875
P6179
1042490839